CALGARY, ALBERTA--(CCNMatthews - May 17, 2007) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE:SSS) announced today that Dr. Alan Moore, President and CEO, will be presenting at the Neurotech Industry Investing and Partnering Conference held at the Westin San Francisco Airport May 17-18, 2007. Dr. Moore will present SCT’s interim Phase IIa clinical safety study with NTxTM-265 in stroke victims as well as outline the company’s future goals and planned clinical programs as part of a panel discussion, Stroke: Prevention, Protection and Recovery.
